Cagrilintide (Research-Grade Synthetic Amylin Analog)

For Laboratory Use Only – Not for Human or Veterinary Application

Product Overview

Cagrilintide is a long-acting synthetic peptide analog of human amylin, designed exclusively for laboratory research applications. Supplied as a lyophilized powder in sterile vials, this compound is intended for preclinical and in vitro investigations related to appetite regulation, gastric motility, and metabolic hormone signaling pathways.

This product is not approved for human or veterinary use.

Product Specifications

Specification	Details
Compound Name	Cagrilintide (Synthetic Amylin Analog)
Available Sizes	8 mg and 10 mg sterile vials
Form	Lyophilized peptide powder
Purity	≥98% (HPLC-verified)
Stability	Stable at –20 °C when sealed and protected from moisture
Storage Conditions	Store at –20 °C in a dry, dark environment
Intended Use	In vitro and preclinical laboratory research only

Scientific Background

Cagrilintide has been studied for its selective binding to amylin receptors involved in satiety regulation and gastric motility. Laboratory investigations have examined its potential influence on:

Appetite Regulation Pathways
- Exploration of central and peripheral food intake control mechanisms
Gastric Emptying Rates
- Evaluation of delayed gastric motility in preclinical models
Adipose Hormone Feedback Loops
- Research into amylin’s interaction with metabolic peptides
Combination Protocols
- Co-administration with GLP-1 analogs in experimental assays assessing potential synergistic metabolic effects

All findings are limited to controlled laboratory models with no clinical efficacy or safety profile established.

Research Applications

Representative research areas include:

Gastrointestinal hormone receptor assays
Receptor binding kinetics and peptide clearance studies
Appetite modulation models in rodent systems
Investigations into non-insulin peptide hormone signaling

These applications are exclusively investigational and intended for use by qualified research laboratories.

Handling & Use

Reconstitute with sterile bacteriostatic water under aseptic conditions
Store reconstituted solutions at 2–8 °C; stable for up to 30 days
Avoid repeated freeze-thaw cycles to maintain stability
Supplied as lyophilized powder only; no diluent, syringes, or ancillary materials provided

Regulatory and Compliance Notice

Research Use Only: For use by qualified laboratory personnel exclusively
Not FDA Approved: No therapeutic, diagnostic, or efficacy claims made
Not for Human or Veterinary Use: Do not inject, ingest, or apply to humans or animals
Qualified Handling: Must be used under institutional research protocols only

Quality Assurance

Cagrilintide is manufactured by HVY Research under sterile, controlled conditions. Each lot is tested for purity and composition consistency. Researchers are expected to follow standard laboratory safety practices, including the use of personal protective equipment (PPE).

Disclaimer

This product is intended solely for scientific research purposes. It is not approved for therapeutic, diagnostic, or clinical applications and is not for human or animal consumption. All information is provided for scientific reference only.